2 FTSE 100 stocks I’d buy in February and 1 I’d sell

Here are some of the stocks I’m buying and selling this month.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every investor loves dividends. They’re the bread and butter of investing. Studies have shown that if you’re not investing with dividends in mind, you stand no chance of matching the market’s returns as around 50% of these come from reinvested dividends. 

That’s why I’m always hunting out the best dividend stocks and trying to avoid the worst, those dividend stocks that are clearly pursuing an unsustainable dividend policy.

Two top dividend picks 

BP (LSE: BP) and GlaxoSmithKline (LSE: GSK) are two dividend champions that look extremely attractive right now. Shares in these two companies both offer a dividend yield of 5% or more, and as we head into 2017, the outlook for both companies is improving.

This time last year, the price of Brent crude oil was around $41 a barrel. Today, the price is more than 25% higher at $54 a barrel, which is great news for BP. Over the past year, the company has been cutting costs to deal with the low oil price environment, and over the next 12 months, these actions should begin to pay off. 

Indeed, during 2017 City analysts expect the company’s earnings per share to grow by 153% and further earnings per share growth of 19% is pencilled-in for 2018. Based on these figures, the shares are trading at a 2017 forward P/E of 14.9 and support a dividend yield of 6.6%. 

Like BP, analysts are predicting strong earnings per share growth for Glaxo during 2017. Growth of 11% is pencilled-in for the year taking earnings to 112p, the highest level since 2012. Based on these estimates the shares are trading at a forward P/E of 14 and support a dividend yield of 5.2%. By 2017, Glaxo’s dividend payout will be covered 1.5 times by earnings per share.

One stock to avoid 

In comparison to Glaxo and BP, EasyJet (LSE: EZJ) looks to me to be a company to avoid during 2017. EasyJet’s advantage over its peers used to be the carrier’s low-cost model. However, over the past few years, this economic benefit has disappeared. 

As a result, City analysts are predicting a 28% decline in earnings per share for the fiscal year to 30 September 2017. These declines follow a 22% fall in earnings per share for 2016. For the year ending 30 September 2017, City analysts expect EasyJet report a pre-tax profit of £385m and earnings per share of 78p. For some comparison, two years ago EasyJet reported a record pre-tax profit of £686m and earnings per share of 139p. 

Even though the company’s dividend yield of 5.7%, is covered twice by earnings per share at present, this payout could come under pressure if earnings continue to decline. Shares in EasyJet currently trade at a forward P/E of 12.2, which looks appropriate considering the group’s rapidly declining profits. All in all, considering EasyJet’s flagging growth it may be best to avoid the company for the time being.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A senior man using hiking poles, on a hike on a coastal path along the coastline of Cornwall.
Growth Shares

How I’d aim to take a Stocks and Shares ISA from £0 to £1m starting today

Jon Smith talks through the strategy he'd look to implement when taking a Stocks and Shares ISA from nothing to…

Read more »

View of Tower Bridge in Autumn
Investing Articles

These 3 FTSE 100 dividend stocks yield an average of 8.26%

With many FTSE 100 share prices slipping, dividend yields are on the rise. Mark Hartley looks at the investment case…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

Investors are rushing to buy these before the Stocks and Shares ISA deadline. Should we join in?

Despite geopolitical troubles causing so much pain in the world, Stocks and Shares ISA investors in the UK are keeping…

Read more »

Mature friends at a dinner party
Investing Articles

How much do you need in a Stocks and Shares ISA for a £10,000 second income?

Ben McPoland highlights a FTSE 100 dividend stock yielding 7% that could contribute nicely to an ISA generating a second…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

How big a Stocks and Shares ISA is needed to target £500 of monthly passive income?

Christopher Ruane explains how a Stocks and Shares ISA could potentially earn someone thousands of pounds in dividends per year.

Read more »

British pound data
Investing Articles

With the stock market down, here are 2 potential ISA bargains to consider right now

When the stock market dips, investors looking at long-term prospects should seek out cheap shares, right? I have my eye…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Want a £1m Stocks and Shares ISA? Step 1 starts before 5 April

Dr James Fox explains why the Stocks and Shares ISA is an incredible vehicle, and why investors may want to…

Read more »

Happy woman commuting on a train and checking her mobile phone while using headphones
Investing Articles

2 dirt-cheap stocks to consider buying for an ISA portfolio in April

This pair of UK shares are down by double digits in recent months. Ben McPoland sees both as stocks to…

Read more »